Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394

A simplification of the protein assay method of Lowry et al. which is more generally applicable

Peterson, G. L. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90043-4 · Cited by 8,531

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Copper, iron and zinc in Alzheimer's disease senile plaques

Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757

Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability

Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452

Mitochondrial abnormalities in Alzheimer's disease

Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367

Protective Role of Methylene Blue in Alzheimer's Disease via Mitochondria and Cytochrome c Oxidase

Atamna, H., & Kumar, R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100414 · Cited by 142

Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition

Gillardon, F., Rist, W., Kußmaul, L., Vogel, J., Berg, M., Danzer, K. M., Kraut, N., & Hengerer, B. (2007) · PROTEOMICS · doi:10.1002/pmic.200600728 · Cited by 141

Strategies for the Inhibition of Protein Aggregation in Human Diseases

Bartolini, M., & Andrisano, V. (2010) · ChemBioChem · doi:10.1002/cbic.200900666 · Cited by 140

Aβ and human amylin share a common toxicity pathway via mitochondrial dysfunction

Lim, Y., Rhein, V. F., Baysang, G., Meier, F., Poljak, A., Raftery, M. J., Guilhaus, M., Ittner, L. M., Eckert, A., & Götz, J. (2010) · PROTEOMICS · doi:10.1002/pmic.200900651 · Cited by 137

Insights into Mitochondrial Dysfunction: Aging, Amyloid-β, and Tau–A Deleterious Trio

Schmitt, K., Grimm, A., Wilkaniec, A., Strosznajder, J. B., Götz, J., & Eckert, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4400 · Cited by 132

Clioquinol Decreases Amyloid-β Burden and Reduces Working Memory Impairment in a Transgenic Mouse Model of Alzheimer's Disease

Grossi, C., Francese, S., Casini, A., Rosi, M. C., Luccarini, I., Fiorentini, A., Gabbiani, C., Luigi Messori, A., Moneti, G., & Casamenti, F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1063 · Cited by 131

Redox Reactions of the α-Synuclein−Cu2+ Complex and Their Effects on Neuronal Cell Viability

Wang, C., Liu, L., Zhang, L., Peng, Y., & Zhou, F. (2010) · Biochemistry · doi:10.1021/bi1010909 · Cited by 126

Mitochondrial dysfunction and Alzheimer's disease

Maruszak, A., & Żekanowski, C. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.004 · Cited by 124

Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease

Crouch, P. J., & Barnham, K. J. (2012) · Accounts of Chemical Research · doi:10.1021/ar300074t · Cited by 125

Transient receptor potential channels in Alzheimer's disease

Yamamoto, S., Wajima, T., Hara, Y., Nishida, M., & Mori, Y. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.03.006 · Cited by 127

Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: On defects in the cytochrome c oxidase complex and aldehyde detoxification

Ohta, S., & Ohsawa, I. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9208 · Cited by 121

Molecular Basis of Alzheimer’s Disease: Focus on Mitochondria

Oliver, D. M. A., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190048 · Cited by 120

APP/Aβ structural diversity and Alzheimer's disease pathogenesis

Roher, A. E., Kokjohn, T. A., Clarke, S. G., Sierks, M. R., Maarouf, C. L., Serrano, G. E., Sabbagh, M., & Beach, T. G. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.007 · Cited by 126

Neurotoxicity of Copper

Bulcke, F., Dringen, R., & Scheiber, I. F. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_16 · Cited by 117

Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆

Bolaños, J. P., Moro, M. Á., Lizasoaín, I., & Almeida, Á. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.009 · Cited by 120

Mitochondrial γ‐secretase participates in the metabolism of mitochondria‐associated amyloid precursor protein

Pavlov, P. F., Wiehager, B., Sakai, J., Frykman, S., Behbahani, H., Winblad, B. G., & Ankarcrona, M. (2010) · The FASEB Journal · doi:10.1096/fj.10-157230 · Cited by 115

The Neurodegenerative Mitochondriopathies

Swerdlow, R. H. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1095 · Cited by 115

Mitochondrial alterations Alzheimer's disease

Baloyannis, S. J., Costa, V., & Michmizos, D. (2004) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/153331750401900205 · Cited by 206

Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity

Cappai, R., & Barnham, K. J. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9469-8 · Cited by 108

Mitochondria, Cybrids, Aging, and Alzheimer's Disease

Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106

Alzheimer’s Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines

Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., & Vécsei, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170929 · Cited by 108

Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases?

Carlo, M. D., Giacomazza, D., Picone, P., Nuzzo, D., & Biagio, P. L. S. (2012) · Free Radical Research · doi:10.3109/10715762.2012.714466 · Cited by 106

Neurological disorders and mitochondria

Cabral‐Costa, J. V., & Kowaltowski, A. J. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.10.003 · Cited by 104

Copper Promotes the Trafficking of the Amyloid Precursor Protein

Acevedo, K. M., Hung, Y. H., Dalziel, A. H., Li, Q., Laughton, K. M., Wikhe, K., Rembach, A., Roberts, B. R., Masters, C. L., Bush, A. I., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128512 · Cited by 109

Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease

Wang, X., Su, B., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.007 · Cited by 102

Altered microglial copper homeostasis in a mouse model of Alzheimer’s disease

Zheng, Z., White, C., Lee, J., Peterson, T. S., Bush, A. I., Sun, G. Y., Weisman, G. A., & Petris, M. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06888.x · Cited by 103

Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases

Szeto, H. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.013 · Cited by 100

Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease?

Elson, J., Herrnstadt, C., Preston, G., Thal, L., Morris, C., Edwardson, J., Beal, M. F., Turnbull, D., & Howell, N. (2006) · Human Genetics · doi:10.1007/s00439-005-0123-8 · Cited by 116

Structural Study of Metastable Amyloidogenic Protein Oligomers by Photo‐Induced Cross‐Linking of Unmodified Proteins

Bitan, G. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)13012-8 · Cited by 97

Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases

Ganji, R., & Reddy, P. H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.614650 · Cited by 96

Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort

Lakatos, A., Derbeneva, O. A., Younes, D., Keator, D. B., Bakken, T. E., Lvova, M., Brandon, M. C., Guffanti, G., Reglődi, D., Saykin, A. J., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.031 · Cited by 97

Evaluation of Coenzyme Q as an Antioxidant Strategy for Alzheimer's Disease

Wadsworth, T. L., Bishop, J. A., Pappu, A. S., Woltjer, R. L., & Quinn, J. F. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14210 · Cited by 95

Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease

Anandatheerthavarada, H. K., & Devi, L. (2007) · The Neuroscientist · doi:10.1177/1073858407303536 · Cited by 95

Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease

Reddy, P. H., Mańczak, M., Yin, X., & Reddy, A. P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170988 · Cited by 97

Disentangling Mitochondria in Alzheimer’s Disease

Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 103

Is Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?

Marco, L. Y. D., Farkas, E., Martin, C. J., Venneri, A., & Frangi, A. F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142976 · Cited by 94

Estradiol and neurodegenerative oxidative stress

Nilsen, J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.12.005 · Cited by 98

Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice

Schüssel, K., Frey, C., Jourdan, C., Keil, U., Weber, C. C., Müller-Spahn, F., Müller, W. E., & Eckert, A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.041 · Cited by 94

Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration

Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 95

Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer’s Drug Discovery

Bu, X., Rao, P. P. N., & Wang, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9301-4 · Cited by 97

Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1

Hernández-Zimbrón, L. F., Luna‐Muñoz, J., Mena, R., Vázquez‐Ramírez, R., Kubli‐Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042344 · Cited by 93

Stabilization of Neurotoxic Soluble β-Sheet-Rich Conformations of the Alzheimer's Disease Amyloid-β Peptide

Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., & Barnham, K. J. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.119909 · Cited by 93

Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice

O’Neal-Moffitt, G., Delic, V., Bradshaw, P. C., & Olcese, J. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0027-6 · Cited by 91

Overexpression of Tfam protects mitochondria against β‐amyloid‐induced oxidative damage in SH‐SY5Y cells

Xu, S., Zhong, M., Zhang, L., Wang, Y., Zhou, Z., Hao, Y., Zhang, W., Yang, X., Wei, A., Pei, L., et al. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07094.x · Cited by 90

Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice

Xu, Y., Xu, K., Sun, Y., Liou, B., Quinn, B., Li, R.-H., Xue, L., Zhang, W., Setchell, K. D. R., Witte, D. P., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu105 · Cited by 88

The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits

Ye, X., Tai, W., & Zhang, D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.004 · Cited by 90

Restored degradation of the Alzheimer’s amyloid‐β peptide by targeting amyloid formation

Crouch, P. J., Tew, D. J., Du, T., Nguyen, D., Caragounis, A., Filiz, G., Blake, R. E., Trounce, I. A., Soon, C. P. W., Laughton, K. M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05870.x · Cited by 88

Mitochondrial therapeutic interventions in Alzheimer’s disease

Giau, V. V., An, S. S. A., & Hulme, J. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.033 · Cited by 87

Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Reddy, P. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.003 · Cited by 88

Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration

Du, H., Guo, L., Wu, X., Sosunov, A. A., McKhann, G. M., Chen, J. X., & Yan, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.004 · Cited by 87

Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease

Collins, A. E., Saleh, T. M., & Kalisch, B. E. (2022) · Antioxidants · doi:10.3390/antiox11020213 · Cited by 93

Human and rodent amyloid-β peptides differentially bind heme: Relevance to the human susceptibility to Alzheimer’s disease

Atamna, H., Frey, W. H., & Ko, N. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.05.003 · Cited by 88

Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells

Dragicevic, N., Delic, V., Cao, C., Copes, N., Lin, X., Mamcarz, M., Wang, L., Arendash, G. W., & Bradshaw, P. C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.018 · Cited by 85

Modes of Aβ toxicity in Alzheimer’s disease

Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87

Pro‐ and Antioxidant Functions of the Peroxisome‐Mitochondria Connection and Its Impact on Aging and Disease

Pascual‐Ahuir, A., Manzanares‐Estreder, S., & Proft, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9860841 · Cited by 87

Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis

Pavlov, P. F., Petersen, C. H., Glaser, E. G., & Ankarcrona, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00892.x · Cited by 84

Targeting mitochondrial dysfunction in neurodegenerative disease: Part II

Burchell, V., Gandhi, S., Deas, E., Wood, N. W., Abramov, A. Y., & Plun‐Favreau, H. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003730434 · Cited by 83

Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases

Kawamata, H., & Manfredi, G. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201709172 · Cited by 86

Alzheimer's Disease and Amyloid: Culprit or Coincidence?

Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 82

Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-β-Mediated Deregulation of Estradiol

Lim, Y., Grimm, A., Giese, M. H., Mensah‐Nyagan, A. G., Villafranca, J. E., Ittner, L. M., Eckert, A., & Götz, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028887 · Cited by 82

Metals in alzheimer's disease: a systemic perspective

Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 80

Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5×FAD mouse model of Alzheimer’s disease

An, J., Zhou, Y., Zhang, M., Xie, Y., Ke, S., Liu, L., Pan, X., & Zhou, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111932 · Cited by 79

Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons

Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., & Liu, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400544 · Cited by 84

Mitochondrial biology in Alzheimer’s disease pathogenesis

Galindo, M. F., Ikuta, I., Zhu, X., Casadesús, G., & Jordán, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06814.x · Cited by 79

Chronic exposure to sub‐lethal beta‐amyloid (Aβ) inhibits the import of nuclear‐encoded proteins to mitochondria in differentiated PC12 cells*

Sirk, D. P., Zhu, Z., Wadia, J. S., Shulyakova, N., Phan, N., Fong, J. C., & Mills, L. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04907.x · Cited by 81

The modulation of metal bio‐availability as a therapeutic strategy for the treatment of Alzheimer's disease

Crouch, P. J., White, A. R., & Bush, A. I. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05918.x · Cited by 78

Membrane‐bound tetramer and trimer Aβ oligomeric species correlate with toxicity towards cultured neurons

Jana, M. K., Cappai, R., Pham, C. L. L., & Ciccotosto, G. D. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13443 · Cited by 76

Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer’s disease

Ding, X.-W., Robinson, M., Li, R., Aldhowayan, H., Geetha, T., & Babu, J. R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105783 · Cited by 73

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease

Calkins, M. J., Mańczak, M., & Reddy, P. (2012) · Pharmaceuticals · doi:10.3390/ph5101103 · Cited by 71

Differences in mitochondrial function in homogenated samples from healthy and epileptic specific brain tissues revealed by high-resolution respirometry

Burtscher, J., Zangrandi, L., Schwarzer, C., & Gnaiger, E. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.10.007 · Cited by 72

Dystrophic neurites of senile plaques in Alzheimer’s disease are deficient in cytochrome c oxidase

Pérez-Gracia, E., Torrejón-Escribano, B., & Ferrer, I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0370-6 · Cited by 71

Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies

Mańczak, M., Sheiko, T. V., Craigen, W. J., & Reddy, P. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130761 · Cited by 73

Peptides as Potential Therapeutics for Alzheimer’s Disease

Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69

Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What

Swerdlow, R. H. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9272-9 · Cited by 69

Blood‐Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism

Tyrrell, D. J., Bharadwaj, M. S., Jorgensen, M. J., Register, T. C., Shively, C. A., Andrews, R. N., Neth, B. J., Keene, C. D., Mintz, A., Craft, S., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7317251 · Cited by 66

Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases

Correia, S. C., Santos, R. X., Perry, G. L., Zhu, X., Moreira, P. I., & Smith, M. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_16 · Cited by 65

Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer’s Disease Model

Niño, S. A., Morales-Martínez, A., Chi-Ahumada, É., Carrizales, L., Salgado‐Delgado, R., Pérez‐Severiano, F., Díaz-Cintra, S. Y., Jiménez-Capdeville, M. E., & Zarazúa, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00278 · Cited by 64

Mitochondrial Microheteroplasmy and a Theory of Aging and Age-Related Disease

Smigrodzki, R. M., & Khan, S. M. (2005) · Rejuvenation Research · doi:10.1089/rej.2005.8.172 · Cited by 62

A Serial Analysis of Gene Expression Profile of the Alzheimer’s Disease Tg2576 Mouse Model

George, A. J., Gordon, L., Beißbarth, T., Koukoulas, I., Holsinger, R. M. D., Perreau, V. M., Cappai, R., Tan, S., Masters, C. L., Scott, H. S., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9112-3 · Cited by 66

Targeting mitochondrial dysfunction in neurodegenerative disease: Part I

Burchell, V., Gandhi, S., Deas, E., Wood, N. W., Abramov, A. Y., & Plun‐Favreau, H. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003652489 · Cited by 64

Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer’s Disease

Cieślik, M., Czapski, G. A., Wójtowicz, S., Wieczorek, I., Wencel, P. L., Strosznajder, R. P., Jaber, V. R., Lukiw, W. J., & Strosznajder, J. B. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01819-y · Cited by 61

Rethinking Alzheimer's Disease Therapy: Are Mitochondria the Key?

Ankarcrona, M., Mangialasche, F., & Winblad, B. G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100327 · Cited by 60

Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease

Uddin, M. S., Mamun, A. A., Rahman, M. A., Behl, T., Perveen, A., Hafeez, A., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200601161703 · Cited by 59

Linker Histone H1 Binds to Disease Associated Amyloid-like Fibrils

Duce, J. A., Smith, D. P., Blake, R. E., Crouch, P. J., Li, Q., Masters, C. L., & Trounce, I. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.038 · Cited by 62

Superoxide Anion, Uncoupling Proteins and Alzheimer’s Disease

Wu, Z., Zhao, Y., & Zhao, B. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-104-2 · Cited by 60

Mitochondria, Cognitive Impairment, and Alzheimer's Disease

Mancuso, M., Calsolaro, V., Orsucci, D., Carlesi, C., Choub, A., Piazza, S., & Siciliano, G. (2009) · International Journal of Alzheimer s Disease · doi:10.4061/2009/951548 · Cited by 58

Multifaceted Roles of Copper Ions in Anticancer Nanomedicine

Yang, S., Song, Y., Hu, Y., Chen, H., Yang, D., & Song, X. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300410 · Cited by 58

Mitochondria Are Related to Synaptic Pathology in Alzheimer′s Disease

Balogiannis, S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/305395 · Cited by 58

Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology

Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55

Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease

Kam, T., Gwon, Y., & Jung, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1706-0 · Cited by 59

Mitochondria in Aging and Alzheimer's Disease

Crouch, P. J., Cimdins, K., Duce, J. A., Bush, A. I., & Trounce, I. A. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0592 · Cited by 54

Mitochondrial links between brain aging and Alzheimer’s disease

Wilkins, H., & Swerdlow, R. H. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00261-2 · Cited by 53

Label-free electrochemical detection of Amyloid beta aggregation in the presence of iron, copper and zinc

Hung, V. W. S., Masoom, H., & Kerman, K. (2012) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2012.05.023 · Cited by 51

Potentiating role of copper on spatial memory deficit induced by beta amyloid and evaluation of mitochondrial function markers in the hippocampus of rats

Behzadfar, L., Abdollahi, M. R., Sabzevari, O., Hosseini, R., Salimi, A., Naserzadeh, P., Sharifzadeh, M. S., & Pourahmad, J. (2017) · Metallomics · doi:10.1039/c7mt00075h · Cited by 52

Common Pathological Processes and Transcriptional Pathways in Alzheimer's Disease and Type 2 Diabetes

Jones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0973 · Cited by 47

Mitochondrial Perturbation in Alzheimer's Disease and Diabetes

Akhter, F., Chen, D., Yan, S. F., & Yan, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.019 · Cited by 48

Folic Acid Plus α-Tocopherol Mitigates Amyloid-β-Induced Neurotoxicity through Modulation of Mitochondrial Complexes Activity1

Figueiredo, C. P., Bicca, M. A., Latini, A., Prediger, R. D., Medeiros, R., & Calixto, J. Β. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101320 · Cited by 47

Copper‐dependent inhibition of cytochrome c oxidase by Aβ1−42 requires reduced methionine at residue 35 of the Aβ peptide

Crouch, P. J., Barnham, K. J., Duce, J. A., Blake, R. E., Masters, C. L., & Trounce, I. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04050.x · Cited by 46

Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases – Role of ER-mitochondria crosstalk

Naia, L., Ferreira, I. L., Ferreiro, E. B., & Rego, A. C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.122 · Cited by 49

Strategic Role for Mitochondria in Alzheimer's Disease and Cancer

Hedskog, L., Zhang, S., & Ankarcrona, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4259 · Cited by 45

Copper‐dependent inhibition of cytochrome c oxidase by Aβ1−42 requires reduced methionine at residue 35 of the Aβ peptide

Crouch, P. J., Barnham, K. J., Duce, J. A., Blake, R. E., Masters, C. L., & Trounce, I. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04050.x · Cited by 46

Amyloid-b Peptide Binds to Cytochrome C Oxidase Subunit 1

Fern, L., Hern, O., Mena, R., Vazquez-ramirez, R., Kubli‐Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012)

P2‐130: Beta‐amyloid peptide 1‐42 binds to N‐terminal fragment of cytochrome C oxidase subunit 1 (COX1)

Hernandez, L. G., Luna‐Muñoz, J., Acero, G., Vázquez‐Ramírez, R., & Gevorkian, G. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.835

Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1

Hernández-Zimbrón, L. F., Luna‐Muñoz, J., Mena, R., Vázquez‐Ramírez, R., Kubli‐Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042344 · Cited by 93

Amyloid-beta Peptide Binds to Cytochrome C Oxidase Subunit 1

Hernandez-Zimbron, L. F., Luna-Muoz, J., Mena, R., Vazquez-Ramirez, R., Kubli‐Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012) · eScholarship (California Digital Library)